Equities

Inspire Veterinary Partners Inc

IVP:NAQ

Inspire Veterinary Partners Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.2555
  • Today's Change0.006 / 2.20%
  • Shares traded3.20k
  • 1 Year change-99.54%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. It specializes in small animal general practice hospitals which serve all manner of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and various other health and wellness offerings.

  • Revenue in USD (TTM)17.13m
  • Net income in USD-19.33m
  • Incorporated2022
  • Employees156.00
  • Location
    Inspire Veterinary Partners Inc780 Lynnhaven Pkwy #400VIRGINIA BEACH 23452United StatesUSA
  • Phone+1 (757) 288-3088
  • Websitehttps://www.inspirevet.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Avalon Globocare Corp1.31m-14.73m3.32m5.00------2.54-19.56-19.561.674.940.0529--13.47261,792.00-59.51-100.94-96.64-134.5121.3324.44-1,125.62-1,011.06---0.32860.6162--4.45-4.28-40.03---51.83--
Biocorrx Inc36.76k-4.29m3.38m5.00------91.84-0.4837-0.48370.0042-1.120.0595--0.3422---697.45-291.68----49.4067.13-11,718.77-3,208.40---2.96-----58.31-25.0413.79------
Mitesco Inc6.00k-4.15m3.50m3.00------582.87-0.6434-0.61210.0004-2.540.0332----2,000.00-1,094.48-246.54----0.00---33,009.50-29,214.62---0.7877---------59.12------
Medical Care Technologies Inc.0.00-1.07m3.64m0.00---------553,570.10-553,570.100.00-389.230.00-------154.94-----------------1.46---------40.06------
Syra Health Corp7.74m-4.25m3.76m78.00--1.13--0.4862-0.6471-0.64711.160.33962.20--7.9899,250.77-120.88---225.30--22.99---54.90-----5,665.830.0673---1.83---38.72------
Selectis Health Inc37.33m-6.17m4.17m574.00------0.1118-2.02-2.0212.19-1.050.8922--15.6765,027.49-14.67-3.03-25.30-3.58-----16.44-4.84---2.981.11---9.4058.97-64.93---47.72--
Mangoceuticals Inc866.79k-9.13m4.84m----0.3413--5.59-6.58-6.580.61527.120.093519.32-----98.48---107.62--58.19---1,052.90--0.3653-38.860.0134--8,082.22---361.07------
Kindly MD Inc3.10m-2.44m4.91m23.00--1.12--1.59-0.4652-0.46520.57430.73760.98675.94471.36134,643.90-77.81---99.26--93.94---78.86--5.36-5.610.0517---0.488--36.34------
Xcelerate Inc3.96m-296.19k4.95m1.00--3.56--1.25-0.0014-0.00140.01890.00321.516.133.90---11.334.24-49.19--71.7174.10-7.481.930.4797-0.82180.7237--6.6310.4317.00--174.06--
CompuMed Inc1.78m-151.00k5.10m8.00--39.16--2.87-0.1337-0.13371.580.09972.3836.714.83---19.92-46.77-48.38-76.7850.4257.04-8.38-25.840.9493-2.930.7744---1.73-5.7164.41---18.75--
Inspire Veterinary Partners Inc17.13m-19.33m5.30m156.00------0.3093-134.72-134.724.54-0.6310.816521.61246.52109,778.20-89.79---190.96--19.47---109.98--0.1311-2.741.20--69.56---206.68------
Ethema Health Corp5.27m943.69k5.41m65.003.18--5.311.030.00020.00020.0014-0.00220.6511--14.1781,064.167.10-37.68--------10.91-94.87---1.777.30--10.8765.34652.41--74.97--
NewGenIvf Group Ltd0.00-690.85k6.51m----0.1532-----0.1999-0.19990.004.190.00-------1.50---1.54--------------0.0944-------237.99------
Caremax Inc784.55m-782.86m6.60m1.45k------0.0084-208.41-208.41208.34-38.730.9776--6.10541,069.60-97.55---160.21---3.31---99.78-----1.951.57--19.01---1,707.99------
Data as of Nov 13 2024. Currency figures normalised to Inspire Veterinary Partners Inc's reporting currency: US Dollar USD

Institutional shareholders

0.90%Per cent of shares held by top holders
HolderShares% Held
UBS Securities LLCas of 30 Jun 202426.47k0.74%
Bartlett & Co. Wealth Management LLCas of 30 Sep 20241.94k0.05%
Tower Research Capital LLCas of 30 Jun 20241.46k0.04%
Harbour Investments, Inc.as of 30 Sep 20241.35k0.04%
Arbor Point Advisors LLCas of 30 Jun 20241.09k0.03%
BofA Securities, Inc.as of 30 Jun 202431.000.00%
Bank of America, NA (Private Banking)as of 30 Jun 20247.000.00%
Moneta Group Investment Advisors LLCas of 30 Jun 20240.000.00%
Citadel Securities LLCas of 30 Jun 20240.000.00%
Osaic Wealth, Inc. (Investment Management)as of 30 Jun 20240.000.00%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.